497 related articles for article (PubMed ID: 8318817)
21. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
Linnemeyer PA; Pollack SB
J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
[TBL] [Abstract][Full Text] [Related]
22. The in vivo effects of steel factor on natural killer lineage cells in murine spleen and bone marrow.
Miller SC; Fleming WH; Zsebo KM; Weissman IL
Nat Immun; 1993; 12(6):293-301. PubMed ID: 7505667
[TBL] [Abstract][Full Text] [Related]
23. Suppression of natural killer cell activity in infant mice occurs after target cell binding.
Dussault I; Miller SC
Nat Immun; 1995; 14(1):35-43. PubMed ID: 7599460
[TBL] [Abstract][Full Text] [Related]
24. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
25. Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ.
Lala PK; Parhar RS
Cancer Res; 1988 Mar; 48(5):1072-9. PubMed ID: 3124954
[TBL] [Abstract][Full Text] [Related]
26. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
[TBL] [Abstract][Full Text] [Related]
27. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
28. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
Klingemann HG; Deal H; Reid D; Eaves CJ
Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
[TBL] [Abstract][Full Text] [Related]
29. Effects of interleukin-2 on bone resorption and natural immunity in osteopetrotic (ia) rats.
Schneider GB; Relfson M
Lymphokine Cytokine Res; 1994 Dec; 13(6):335-41. PubMed ID: 7703307
[TBL] [Abstract][Full Text] [Related]
30. Generation of natural killer cells from long-term cultures of mouse bone marrow.
Vecchini F; Delfino D; Patrene KD; DeLeo A; Lu L; Herberman RB; Boggs SS
Nat Immun; 1993; 12(1):1-16. PubMed ID: 8431659
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human interleukin-1 alpha: a potent bio-immunomodifier in vivo in immunosuppressed mice induced by cyclophosphamide, retroviral infection and surgical stress.
Shen RN; Wu B; Lu L; Kaiser HE; Broxmeyer HE
In Vivo; 1994; 8(1):59-63. PubMed ID: 8054512
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the possible causes of decreasing NK cell activity in tumor-bearing mice. I. The number of NK cells in the spleens of tumor-bearing mice is higher than that in normal mice].
Fu JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Dec; 11(6):421-4. PubMed ID: 2534577
[TBL] [Abstract][Full Text] [Related]
33. Regulation of natural killer cell production in bone marrow of mice: no evidence for negative feedback control.
Bilge A; Pollack SB
Nat Immun; 1992; 11(3):156-66. PubMed ID: 1392403
[TBL] [Abstract][Full Text] [Related]
34. Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer.
Wiltrout RH; Boyd MR; Back TC; Salup RR; Arthur JA; Hornung RL
J Immunol; 1988 May; 140(9):3261-5. PubMed ID: 3258894
[TBL] [Abstract][Full Text] [Related]
35. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
36. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
37. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
Kalland T; Forsberg JG
J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
[TBL] [Abstract][Full Text] [Related]
38. Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.
Talmadge JE; Phillips H; Schindler J; Tribble H; Pennington R
Cancer Res; 1987 Nov; 47(21):5725-32. PubMed ID: 3499218
[TBL] [Abstract][Full Text] [Related]
39. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
40. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.
Hackett J; Tutt M; Lipscomb M; Bennett M; Koo G; Kumar V
J Immunol; 1986 Apr; 136(8):3124-31. PubMed ID: 3958492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
